Emma Morton-Eggleston, MD, MPH
December 23rd, 2013
Statins: Targeting Risk, but Risking Diabetes?
Emma Morton-Eggleston, MD, MPH and Richard Lehman, BM, BCh, MRCGP
Emma Morton-Eggleston and Richard Lehman share their correspondence with us, in which they debate whether it’s worth using statins to target CV risk if they might increase other risks, such as diabetes.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?